| Name | Title | Contact Details |
|---|
Strategic Gears is the biggest local management consultancy firm in Saudi Arabia; It has offices in Egypt, Qatar and UK. Providing multidisciplinary services for both the private and public sectors. The company offers consulting solutions in the areas of Strategy, Marketing, Organizational Excellence and Digital, to a range of clients in both the public and private sectors. The company is heavily involved in the transformation era of Saudi Arabia, driven by the Vision 2030 initiatives. Strategic Gears prides itself on its ability to be a knowledge hub for the Saudi market, publishing reports on a monthly basis on the current state of the Kingdoms economy as well as hot topics in both the public and private sectors, including an annual coverage of the Saudi budget, and other reports on the Kingdoms macroeconomic performance, labour market, digital transformation and AI, among others. The company, which was founded in late 2015, has quickly evolved from a small team to more than 230 employees in all its branches.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
The PWHL is first-of-its-kind womens hockey league that brings together the best players in the world. Our league is comprised of six teams in North America, including: PWHL Boston, PWHL Minnesota, PWHL Montréal, PWHL New York, PWHL Ottawa, and PWHL Toronto.
Precision AQ is a global life science commercialization vendor that specializes in Health Economics and Outcomes Research (HEOR), pricing, and market access consulting for pharmaceutical and biotech companies. Headquartered in New York City, the company operates with a strong emphasis on remote work. Precision AQ is dedicated to transforming patient lives by improving access to life-changing therapies through innovative strategies and data-driven approaches. The company offers a wide range of services to support clients throughout the healthcare journey. These include research, strategy, and product development, as well as marketing, branding, and public relations. Precision AQ also focuses on generating evidence for HEOR, optimizing payer access, and facilitating investor relations. Their expertise helps clients navigate the complexities of the market and enhance their presence among healthcare professionals and patients.